I agree with you to a point groins.
However...
Real company news is what matters and being on the N (where biotech's are understood and appreciated) when great things get announced is going to be better than sitting only on the ASX (where as we all know biotechs are very under appreciated).
I believe that as more and more good company news flows as well as trial data, the more US based articles will start to pay attention and report and that raises investor awareness in general in the US and the world. All these factors are going to help not hinder Prima Biomed, patients ultimately but also us investors.
I agree with you to a point groins.However...Real company news...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $435.7M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.5¢ | $469.8K | 1.579M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 297652 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 7500 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |